Nanoparticle-Enhanced Impedance Biosensor for Portable Diagnostics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Impedance-based biosensors face limitations in sensitivity and complexity, particularly with interdigitated electrodes, which require extensive electronics and are not suitable for portable point-of-care diagnostics due to the need for broad frequency range impedance spectroscopy and model fitting.
Innovation Solution
A biosensor design incorporating interdigitated microelectrodes with gold nanoparticles coated with mercaptoundecanoic acid, where the nanoparticles are immobilized between electrodes, altering electrical impedance through double layer capacitance, allowing for sensitive detection of biomolecules using a narrower frequency range and simpler electronics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If broad frequency range impedance spectroscopy and model fitting are used to detect target biomolecules with interdigitated electrodes, then detection sensitivity is improved, but device complexity and expense increase due to required electronics and computer components
Solution Approach 1:
The patent extracts and eliminates the complex broad frequency range impedance spectroscopy and model fitting components from the detection system. Instead, it uses a simplified single-frequency or narrow-frequency impedance measurement approach that achieves adequate detection sensitivity without requiring extensive electronics or computer processing, thereby resolving the contradiction between detection sensitivity and device complexity
Solution Approach 2:
The patent changes the measurement parameter from broad frequency range impedance spectroscopy to single-frequency or narrow-frequency impedance measurement. This parameter change simplifies the required electronics and processing while maintaining sufficient detection capability for point-of-care applications, thus resolving the contradiction between measurement precision and device complexity
2Measurement precision
If broad frequency range impedance spectroscopy is used for target detection, then measurement precision is improved, but the device size and expense increase due to required electronics and computer components
Solution Approach 1:
The patent removes the unnecessary broad frequency range spectroscopy and model fitting components from the system, retaining only the essential single-frequency or narrow-frequency impedance measurement capability. This extraction reduces device size and expense while preserving adequate detection accuracy for point-of-care use
Solution Approach 2:
Instead of using the conventional approach of broad frequency range impedance spectroscopy followed by model fitting to achieve detection, the patent inverts the approach by using simplified single-frequency or narrow-frequency impedance measurement that directly provides sufficient detection capability without requiring complex processing, thus reducing device size and expense
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances sensitivity and accuracy of biomolecule detection, enabling the development of portable, inexpensive, and handheld devices for point-of-care diagnostics by measuring impedance changes at specific frequencies, facilitating the detection of various biomolecules.
Implementation Method 1
altering electrical impedance through double layer capacitance
Data Source
AI summary
An impedance based biosensor and method for detecting a target biomolecule in a sample are provided. The biosensor has a substrate, and first and second spaced-apart electrodes disposed at the substrate. A molecular recognition element (MRE) for binding with the target is bound to the substrate between the first and second electrodes. The biosensor also has a nanoparticle having an MRE bound to its surface. In the presence of the target, the nanoparticle is immobilized between the first and second electrodes due to binding of the target biomolecule with the first MRE and binding of the target biomolecule with the second MRE. A measurable change in electrical impedance across the first and second electrodes occurs due to the immobilization of the nanoparticle between the first and second electrodes.